On October 12, 2023, France published an official decree on the requirements for endocrine-disrupting substances. The decree specifies a list of substances with endocrine-disrupting properties, and substances confirmed and suspected to be endocrine disruptors are listed in Annex I of the decree, in Table A and Table A bis (covering 128 substances, including 126 SVHC substances, cholecalciferol (vitamin D3) and mancozeb). Substances suspected to be endocrine disruptors are listed in Table B and Table B bis of Annex I (Table B and Table B bis are currently empty).